AVROBIO Inc.

11/24/2021 | Press release | Distributed by Public on 11/24/2021 06:05

AVROBIO Presents Clinician Experience with FAB-GT Clinical Trial and Updated Safety Data for Investigational Gene Therapies in Fabry Disease and Gaucher Disease Type 1